• Skip to primary navigation
  • Skip to main content
Neural Stem Cell Institute, Rensselaer NY

Neural Stem Cell Institute, Rensselaer NY

Stem cell research and applications in the treatment of diseases like Retinitis Pigmentosis, Alzheimer's, Parkinson's, Spinal Cord Injury, Retinal Degeneration. Home of SallyTemple's lab.

  • Home
  • Support NSCI
  • Research
    • Alzheimer’s Program
    • Retinal Disease: Age-Related Macular Degeneration
    • Parkinson’s Disease Program
    • Spinal Cord Injury Program
    • Computing @ NSCI
  • NeuraCell
  • Tau Consortium
  • News
  • About Us
    • Our Team
  • Contact Us
    • Careers
    • Volunteer Internship
    • Collaboration Inquiries
    • Media Inquiries
  • Show Search
Hide Search

New Study by NSCI Researchers Revolutionizes Stem Cell Culture

pressreleasesheader

Stem Cell News

March 13, 2013

New Study by NSCI Researchers Revolutionizes Stem Cell Culture

Neural Stem Cell Institute
Regenerative Research Foundation

New Study by NSCI Researchers Revolutionizes
Stem Cell Culture

RENSSELAER, N.Y. (March 13, 2013) – Stem cell research is growing by leaps and bounds globally in both research and company laboratories. Stem cells grown in the culture dish provide the millions of cells needed for valuable therapy and research. Stem cell culture is laborious and expensive, but a recent study reports a dramatic improvement in stem cell production.

A team of researchers at The Neural Stem Cell Institute (NSCI) has overcome a key limitation of current stem cell methodology by developing a new culture medium additive that is bioengineered to feed stem cells continuously over several days. The StemBead additive increases the quantity and quality of stem cells grown under standard culture conditions while significantly reducing cost and labor.

Current methodology has researchers adding fresh FGF2 seven days a week, but still, most of the FGF2 breaks down rapidly. To maintain constant growth factor levels, the NSCI team created a sustained release StemBeadFGF2 additive that steadily releases into the stem cell cultures and only has to be added twice a week. The technology has been licensed to a newly formed biotechnology company, StemCulture which has received many positive reviews from researchers at top institutes in the United States and from labs around the world using the StemBeadFGF2 product.

For a copy of the published manuscript, please visit the peer-reviewed article at:

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0056289

###

MEDIA CONTACTS:

Kathy Condon

Condon Communications

PH: 518-436-1103

condonkathy@gmail.com

OR

Cindy Butler, Executive Administrator

Neural Stem Cell Institute

518-694-8188

cindybutler@nynsci.org

< Back to News

Neural Stem Cell Institute, Rensselaer NY

Copyright © 2025 - This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • Home
  • Support NSCI
  • Research
  • NeuraCell
  • Tau Consortium
  • News
  • About Us
  • Contact Us